AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
GLP-1 Drugs Are Expanding Beyond Obesity, and Neurology May Be the Next Real Test
Two reports this week spotlight the widening clinical conversation around GLP-1 medicines, including their potential role beyond weight loss and promising signals in chronic migraine. Together they show how one of medicine’s hottest drug classes is evolving into a broader platform story that could reshape care pathways well outside endocrinology.
GLP-1 Expansion Story Is Getting More Practical: Comorbidities, Not Hype, Will Decide the Next Market
A new AJMC interview on GLP-1 medications points to continued interest in uses beyond weight loss, reflecting the drug class’s widening clinical and commercial ambition. The next phase, however, will depend less on broad enthusiasm than on disease-specific evidence, reimbursement logic, and tolerability in real-world populations.
FDA’s New Weight-Loss Device Guidance Raises the Bar for Obesity Medtech
The FDA has finalized guidance for weight-loss devices, giving manufacturers a clearer regulatory roadmap as obesity treatment expands beyond drugs. The document matters because it signals how the agency expects companies to frame safety, effectiveness, and risk-benefit in a market increasingly shaped by GLP-1 therapies.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.